10:04 AM EST - Medexus Pharmaceuticals Inc. : Announced that CEO Ken d’Entremont, and Chief Financial Officer Marcel Konrad will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13. Medexus Pharmaceuticals Inc.
shares T.MDP are trading up $0.04 at $2.76.
